Adar Poonawalla, Serum Institute of India CEO (Dhiraj Singh/Bloomberg via Getty Images)
April 25, 2023 03:00 PM EDT
Deals
Manufacturing

Serum In­sti­tute sub­sidiary in­vests an­oth­er $150M in­to Bio­con

Tyler Patchen

News Reporter

Biosim­i­lar man­u­fac­tur­er Bio­con said Tues­day that the Serum In­sti­tute of In­dia is mak­ing an­oth­er $150 mil­lion in­vest­ment, dou­bling a pri­or in­vest­ment from last No­vem­ber. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times